Covington advised lead investors Abingworth and other syndicate members on the round. Ascend closed its $130 million Series A fundraise. Ascend will use the proceeds to launch...
Ascend Gene & Cell Therapies’ $130 Million Series A Fundraise
Humacyte’s $160 Million Funding Arrangement
Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
Elliott, Patient Square and Veritas’ Acquisition of Syneos Health
Kirkland & Ellis advised Patient Square Capital on the transaction. Gibson Dunn & Crutcher LLP served as legal counsel to Elliott and Millbank LLP and Covington & Burling...
OrbiMed’s $75 Million Debt Financing
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
Imdex’s Victory before the U.S. International Trade Commission
Covington advised Imdex Ltd. on the deal. Imdex Ltd., a global mining technology company that enables drilling contractors and resource companies to find, define and mine...
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
Petrichor’s $30 Million Financing of VERO Biotech Inc.
Covington advised Petrichor on the deal. Petrichor, a leading healthcare-dedicated growth capital provider, announced its $30 million financing of VERO Biotech Inc., a commercial-stage healthcare business dedicated...
Dedrone Holdings’ Acquisition of Aerial Armor
Crowell & Moring advised founders of Aerial Armor on the deal. Aerial Armor announced the sale of the company to Dedrone Holdings Inc., a leader in...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Advent International’s Acquisition of Maxar Technologies
Wachtell, Lipton, Rosen & Katz advised Maxar on the deal. Milbank served as Maxar’s legal advisor with respect to certain space industry and regulatory matters. Weil,...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
Roivant Sciences’ $150 Million Equity Offering
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...